Back to PFE Stock Lookup

Pfizer (PFE) – Press Releases

Nov 19, 2014 08:00 AM Nodality Develops Disease-Associated PD-1 Assay System for Application in Immuno-oncology
Nov 18, 2014 08:30 AM TRUMENBA® (Meningococcal Group B Vaccine) is Now Available
Nov 18, 2014 08:00 AM Nodality, Inc. Announces Data Presentation from Collaborative Program with UCB at American College of Rheumatology 2014 Annual Meeting
Nov 17, 2014 08:30 AM Nodality, Inc. Announces Data Presentations from Systemic Lupus Erythematosus Collaborative Programs at American College of Rheumatology 2014 Annual Meeting
Nov 17, 2014 08:00 AM Portola, Bristol-Myers Squibb and Pfizer Announce Statistically Significant Results From the First Part of the Phase 3 ANNEXA(TM)-A Studies of Investigational Andexanet Alfa With Eliquis (apixaban)
Nov 17, 2014 03:40 AM Merck KGaA, Darmstadt, Germany, Announces Global Strategic Alliance with Pfizer on Anti-PD-L1 to Accelerate Presence in Immuno-Oncology
Nov 17, 2014 02:53 AM Pfizer Forms Global Strategic Alliance with Merck KGaA, Germany, to Jointly Develop and Commercialize Anti-PD-L1 to Accelerate Presence in Immuno-Oncology
Nov 13, 2014 11:00 AM Novel Agreement Expands Access to Pfizer’s Contraceptive, Sayana® Press, for Women Most in Need in the World’s Poorest Countries
Nov 12, 2014 08:00 AM Pfizer Highlights Leadership in Rheumatology and Inflammation with Data to be Presented at the ACR/ARHP 2014 Annual Meeting
Nov 5, 2014 11:00 AM Pfizer Invites Public To Listen To Webcast Of Pfizer Discussion At Healthcare Conference
Oct 29, 2014 02:44 PM Pfizer Receives FDA Accelerated Approval for TRUMENBA® (Meningococcal Group B Vaccine) for the Prevention of Invasive Meningococcal B Disease in Adolescents and Young Adults
Oct 29, 2014 08:30 AM Pfizer’s PRISTIQ® (desvenlafaxine) Demonstrates Low Potential For Sexual Dysfunction in Adults with Major Depressive Disorder
Oct 28, 2014 07:00 AM PFIZER REPORTS THIRD-QUARTER 2014 RESULTS
Oct 27, 2014 08:05 AM DURECT Provides Update on REMOXY® and POSIDUR™ Programs
Oct 27, 2014 08:00 AM Pfizer to Discontinue Agreement on REMOXY™ (oxycodone) Extended-Release Capsules CII
Oct 23, 2014 04:05 PM Pfizer Declares 26-Cent Fourth-Quarter 2014 Dividend
Oct 23, 2014 08:00 AM Pfizer Wins SUTENT® Patent Case In Delaware District Court
Oct 20, 2014 09:00 AM ViiV Healthcare Expands Program to Reduce HIV Disparities in Southern U.S.
Oct 17, 2014 04:38 PM FDA Approves Abuse Deterrent Labeling for EMBEDA® (morphine sulfate and naltrexone hydrochloride) Extended-Release (ER) Capsules CII
Oct 13, 2014 08:00 AM Pfizer Announces FDA Acceptance Of Palbociclib New Drug Application With Priority Review
Oct 10, 2014 08:00 AM Pfizer to Present New Data Evaluating Safety, Tolerability and Immunogenicity of its Investigational Staphylococcus aureus Vaccine Candidate at IDWeek 2014™
Oct 8, 2014 08:30 AM Pfizer and Breast Cancer Leaders Join Together to Increase Understanding and Dispel Myths about Metastatic Breast Cancer
Oct 8, 2014 08:00 AM Pfizer To Present Safety And Immunogenicity Data From A Phase 2 Study Of Its Investigational Meningococcal Group B Vaccine, Bivalent rLP2086, Co-Administered With A Licensed Human Papillomavirus Vacci
Oct 2, 2014 05:10 PM Zoetis Declares Fourth Quarter 2014 Dividend
Oct 1, 2014 08:00 AM Portola Pharmaceuticals Announces Phase 3 ANNEXA(TM)-A Study of Andexanet Alfa and Eliquis (Apixaban) Met Primary and Secondary Endpoints With High Statistical Significance
Sep 30, 2014 08:30 AM Zoetis to Host Webcast and Conference Call on Third Quarter 2014 Financial Results
Sep 29, 2014 08:00 PM Pfizer And Kyowa Hakko Kirin To Collaborate On Immuno-Oncology Combination Study
Sep 26, 2014 09:01 AM GlycoMimetics Announces a Delay in the Initiation of the Phase 3 Trial With Rivipansel
Sep 26, 2014 07:30 AM Pain Therapeutics Expands Pipeline With FENROCK(TM), an Abuse-Deterrent Pain Patch
Sep 25, 2014 08:00 AM Pfizer Completes Acquisition Of InnoPharma
Sep 23, 2014 10:00 AM Pfizer Invites Public to View and Listen to Webcast of October 28 Conference Call with Analysts
Sep 23, 2014 08:00 AM Kim Cattrall Encourages Women to Embrace Menopause with Style
Sep 22, 2014 08:00 AM Bristol-Myers Squibb and Pfizer Announce Charitable Donations of More Than $1 Million to Support Cardiovascular Education for Patients and Caregivers
Sep 19, 2014 08:00 AM Pfizer Foundation Provides $2 Million In Grants To Support ‘Last-Mile’ Vaccine Coverage In Africa
Sep 16, 2014 08:30 AM Zoetis Ranked Among Top Ten Companies for Working Mothers
Sep 3, 2014 10:00 AM Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Sep 3, 2014 08:00 AM Zoetis Granted Conditional License for Porcine Epidemic Diarrhea Vaccine*
Aug 30, 2014 05:15 AM Secondary Analysis of AMPLIFY-EXT Examining Predictors of Hospitalization Presented at ESC Congress: Eliquis (apixaban) Significantly Reduced the Risk of All-Cause Hospitalization Versus Placebo in Pa
Aug 29, 2014 10:13 AM InnoPharma Announces FDA Approval of Decitabine for Injection, a Generic Version of DACOGEN®
Aug 28, 2014 01:15 PM Pfizer and Protalix BioTherapeutics Announce FDA Approval of Pediatric Indication for ELELYSO™ (taliglucerase alfa) for Injection, for Intravenous Use for the Treatment of Type 1 Gaucher Disease
Aug 28, 2014 08:00 AM Pfizer’s Investigational Vaccine Candidate for Clostridium difficile Receives U.S. Food and Drug Administration Fast Track Designation
Aug 26, 2014 08:00 AM Pfizer And Merck To Collaborate On Study Evaluating Novel Anti-Cancer Combination Regimen
May 19, 2014 08:05 AM Semi-Annual Changes to the NASDAQ OMX CRD Global Sustainability Index
Jan 13, 2014 08:00 AM Portola Pharmaceuticals Enters Second Clinical Collaboration Agreement With Bristol-Myers Squibb and Pfizer to Study Andexanet Alfa* (PRT4445), Investigational Factor Xa Inhibitor Reversal Agent, With

Back to PFE Stock Lookup